Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Wen-Kai WengSandra Horning

Abstract

Rituximab has been given after autologous hematopoietic cell transplantation for recurrent or refractory B-cell lymphoma with the goal of eradicating minimal residual disease. Our previous report showed that administration of two courses of rituximab after transplantation is feasible, with encouraging clinical outcomes after a short follow-up. However, neutropenia after the first or second post-transplantation rituximab treatment occurred in 52% of patients. We previously reported that polymorphisms of two immunoglobulin G Fc receptors predict rituximab response, presumably because of their role in antibody-dependent cellular cytotoxicity. In the current report, we determine whether FcgammaR polymorphisms are correlated with clinical outcomes in 33 patients with B-cell non-Hodgkin's lymphoma who received post-transplantation rituximab. Genomic DNA was used for FcgammaRIIIa V/F or the FcgammaRIIa H/R genotyping. The FcgammaR polymorphisms were then correlated with the incidence of rituximab-induced neutropenia, event-free survival (EFS), and overall survival (OS). The FcgammaRIIIa 158 V allele dose was correlated with a higher incidence of rituximab-induced neutropenia. The odds of neutropenia after the first or second post-tran...Continue Reading

References

Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P McLaughlinB K Dallaire
Dec 29, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·I W FlinnR F Ambinder
Nov 19, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hakan KayaDavid D Hurd
Jun 6, 2003·British Journal of Haematology·Kritika ChaiwatanatornFrank Firkin
Jun 27, 2003·The New England Journal of Medicine·Eric VoogPhilippe Solal-Céligny
Sep 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai Weng, Ronald Levy
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven P TreonEdward A Fox
Jun 9, 2005·The Journal of Experimental Medicine·Yoshihiro UedaGarnett Kelsoe
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Greg A LazarBassil I Dahiyat
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Jul 15, 2006·Leukemia & Lymphoma·Peter McLaughlin
Oct 20, 2006·International Journal of Hematology·Kenji FukunoHisataka Moriwaki
Nov 3, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E NittaM Kurokawa
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wu ZhangHeinz-Josef Lenz
Oct 6, 2007·The British Journal of Dermatology·R Rios-FernándezN Ortego-Centeno
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonino MusolinoAndrea Ardizzoni
May 14, 2008·Annals of the Rheumatic Diseases·H MarotteP Miossec

❮ Previous
Next ❯

Citations

May 25, 2012·The New England Journal of Medicine·David G Maloney
Jan 5, 2013·Journal of Hematology & Oncology·James D MellorAlexander Dobrovic
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert L FerrisSoldano Ferrone
Aug 29, 2013·Future Oncology·Chan Y CheahJohn F Seymour
Apr 20, 2013·Journal of Immunological Methods·Lionel LoubakiRenée Bazin
Sep 19, 2014·Molecular Diagnosis & Therapy·Ksenia Matlawska-WasowskaStuart S Winter
Aug 19, 2014·Hematology·Yasuyuki AraiAkifumi Takaori-Kondo
Apr 10, 2015·The American Journal of Case Reports·Tatiana ReitblatOlga Reitblat
Apr 17, 2015·Multiple Sclerosis and Related Disorders·Annika PlateTania Kümpfel
Aug 3, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Koichi KameiShuichi Ito
Sep 20, 2016·Clinical Pharmacokinetics·Daphne BertholeeAndré B P van Kuilenburg
Aug 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bo GaoHoward Gurney
Dec 3, 2014·Seminars in Oncology·Sumita TrivediRobert L Ferris
Mar 9, 2013·Toxicologic Pathology·Nancy E Everds, Jacqueline M Tarrant
Mar 19, 2014·The Journal of Rheumatology·Rita AbdulkaderRichard A Watts
Nov 26, 2010·Current Opinion in Hematology·Cliona GrantKieron Dunleavy
Feb 16, 2013·Nature Reviews. Immunology·Inessa Schwab, Falk Nimmerjahn
Sep 29, 2019·Current Hematologic Malignancy Reports·Pallawi TorkaFrancisco J Hernandez-Ilizaliturri
Nov 15, 2011·Current Opinion in Hematology·Ofir WolachMeir Lahav
Dec 7, 2011·European Journal of Immunology·Corina BuecheleHelmut R Salih
Feb 28, 2019·Bone Marrow Transplantation·Shalev FriedElad Jacoby
Aug 27, 2017·Journal of Clinical Immunology·Aurélien GuffroyUNKNOWN DEFI study group
Sep 1, 2018·International Journal of Rheumatic Diseases·Sanket ShahVir Singh Negi
Nov 26, 2010·European Journal of Haematology·Tsuneaki HirakawaKoiti Inokuchi
Oct 27, 2020·International Journal of STD & AIDS·G AlfanoG Cappelli
Oct 16, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Michael ZhongVilija Jokubaitis
May 1, 2021·Cancers·Cecilia Nakid-CorderoVincent Vieillard
Jun 3, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Mariano MarrodanJorge Correale
Jun 26, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giorgia T ManiscalcoValentino Manzo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.